These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12403310)

  • 1. Pimecrolimus: a new treatment for seborrheic dermatitis.
    Crutchfield CE
    Cutis; 2002 Oct; 70(4):207-8. PubMed ID: 12403310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical pimecrolimus in the treatment of seborrheic dermatitis.
    Brownell I; Quan LT; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):13. PubMed ID: 12952760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
    Cicek D; Kandi B; Bakar S; Turgut D
    J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids.
    Cunha PR
    Acta Derm Venereol; 2006; 86(1):69-70. PubMed ID: 16585998
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis.
    Zhao J; Sun W; Zhang C; Wu J; Le Y; Huang C; Liu Y; Xiang L
    J Cosmet Dermatol; 2018 Feb; 17(1):90-94. PubMed ID: 28589618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial.
    Firooz A; Solhpour A; Gorouhi F; Daneshpazhooh M; Balighi K; Farsinejad K; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Aug; 142(8):1066-7. PubMed ID: 16924062
    [No Abstract]   [Full Text] [Related]  

  • 9. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream.
    Gorman CR; White SW
    Arch Dermatol; 2005 Sep; 141(9):1168. PubMed ID: 16172323
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy.
    Cook BA; Warshaw EM
    Am J Clin Dermatol; 2009; 10(2):103-18. PubMed ID: 19222250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with repetitive use of pimecrolimus: exploring the effective and safe use in the treatment of relapsing seborrheic dermatitis.
    Tatlican S; Eren C; Oktay B; Eskioglu F; Durmazlar PK
    J Dermatolog Treat; 2010 Mar; 21(2):83-5. PubMed ID: 19391059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into pimecrolimus experience in seborrheic dermatitis: close follow-up with exact mean cure and remission times and side-effect profile.
    Tatlican S; Eren C; Eskioglu F
    J Dermatolog Treat; 2009; 20(4):198-202. PubMed ID: 19255921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical pimecrolimus in the treatment of human allergic contact dermatitis.
    Amrol D; Keitel D; Hagaman D; Murray J
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):563-6. PubMed ID: 14700441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ; Frankel A; Sohn A; Lebwohl M
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials.
    Ang-Tiu CU; Meghrajani CF; Maano CC
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):91-7. PubMed ID: 22142161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
    Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
    Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
    Koc E; Arca E; Kose O; Akar A
    J Dermatolog Treat; 2009; 20(1):4-9. PubMed ID: 18677657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.